Rac1-dependent transcriptional up-regulation of p27Kip1 by homophilic cell-cell contact in vascular endothelial cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 10, 2007, Pages 1500-1510

  Hirano, Mayumi ^a   Kanaide, Hideo ^a,b   Hirano, Katsuya ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cell cycle; Cyclin dependent kinase inhibitor; Expression; Promoter; Protein transduction

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; NSC 23766; NUCLEOTIDE; PROTEIN; PROTEIN INHIBITOR; RAC1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL COMMUNICATION; CELL CYCLE ARREST; CODON; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

AMINOQUINOLINES; ANIMALS; BASE SEQUENCE; CATTLE; CELL ADHESION; CELL CYCLE; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PYRIMIDINES; RAC1 GTP-BINDING PROTEIN; SWINE; UP-REGULATION;

EID: 34848855738     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.08.001     Document Type: Article

References (48)

1. Lampugnani M.G., and Dejana E. Interendothelial junctions: structure, signalling and functional roles. Curr. Opin. Cell Biol. 9 (1997) 674-682
2. Augustin H.G., Kozian D.H., and Johnson R.C. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. BioEssays 16 (1994) 901-906
3. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8 (1994) 9-22
4. Kip1 during the contact-induced growth arrest in the vascular endothelial cells. Exp. Cell Res. 271 (2001) 356-367
5. 1-phase progression. Genes Dev. 13 (1999) 1501-1512
6. Chen D., Walsh K., and Wang J. Regulation of cdk2 activity in endothelial cells that are inhibited from growth by cell contact. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 629-635
7. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., Yew P.R., Draetta G.F., and Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269 (1995) 682-685
8. Carrano A.C., Eytan E., Hershko A., and Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1 (1999) 193-199
9. Patel Y.M., and Lane M.D. Mitotic clonal expansion during preadipocyte differentiation: calpain-mediated turnover of p27. J. Biol. Chem. 275 (2000) 17653-17660
10. Kip1 by N-terminal cleavage and their sequence requirements. FEBS Lett. 574 (2004) 111-115
11. Kip1 expression by mitogenic and hypertrophic factors: involvement of transcriptional and posttranscriptional mechanisms. J. Cell Biol. 148 (2000) 543-556
12. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res. 55 (1995) 1206-1210
13. Kip1 gene promoter. FEBS Lett. 411 (1997) 1-6
14. Kip1. Gene 180 (1996) 113-120
15. Zhang Y., and Lin S.-C. Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter. Biochim. Biophys. Acta 1353 (1997) 307-317
16. 3-treated HL60 cells. Cancer Res. 57 (1997) 2851-2855
17. Kip1 in a human gastric carcinoma cell line. Cell Growth Differ. 8 (1997) 47-52
18. Kip1 is involved in thyroid hormone-mediated neuronal differentiation. J. Biol. Chem. 274 (1999) 5026-5031
19. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10 (1996) 142-153
20. Kip1 gene promoter that lacks vitamin D response elements. J. Biol. Chem. 274 (1999) 32309-32317
21. Braga V.M., and Yap A.S. The challenges of abundance: epithelial junctions and small GTPase signalling. Curr. Opin. Cell Biol. 17 (2005) 466-474
22. Kawakatsu T., Shimizu K., Honda T., Fukuhara T., Hoshino T., and Takai Y. trans-Interactions of nectins induce formation of filopodia and lamellipodia through the respective activation of Cdc42 and Rac small G proteins. J. Biol. Chem. 277 (2002) 50749-50755
23. Lampugnani M.G., Zanetti A., Breviario F., Balconi G., Orsenigo F., Corada M., Spagnuolo R., Betson M., Braga V., and Dejana E. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Mol. Biol. Cell 13 (2002) 1175-1189
24. Hirano K., Hirano M., Nishimura J., and Kanaide H. A critical period requiring Rho proteins for cell cycle progression uncovered by reversible protein transduction in endothelial cells. FEBS Lett. 570 (2004) 149-154
25. 2+ sensitivity in an intact coronary artery. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 464-469
26. Shiga N., Hirano K., Hirano M., Nishimura J., Nawata H., and Kanaide H. Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery. Circ. Res. 96 (2005) 1014-1021
27. Yufu T., Hirano K., Bi D., Hirano M., Nishimura J., Iwamoto Y., and Kanaide H. Rac1 regulation of surface expression of protease-activated receptor-1 and responsiveness to thrombin in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1506-1511
28. Kip1. Biochem. J. 353 (2001) 51-57
29. Kip1, a cyclin-dependent kinase inhibitor. Biochem. Biophys. Res. Commun. 274 (2000) 37-42
30. Gaboli M., Kotsi P.A., Gurrieri C., Cattoretti G., Ronchetti S., Cordon-Cardo C., Broxmeyer H.E., Hromas R., and Pandolfi P.P. Mzf1 controls cell proliferation and tumorigenesis. Genes Dev. 15 (2001) 1625-1630
31. Gao Y., Dickerson J.B., Guo F., Zheng J., and Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7618-7623
32. Zeng L., Xu H., Chew T.L., Chisholm R., Sadeghi M.M., Kanwar Y.S., and Danesh F.R. Simvastatin modulates angiotensin II signaling pathway by preventing Rac1-mediated upregulation of p27. J. Am. Soc. Nephrol. 15 (2004) 1711-1720
33. Liu W.F., Nelson C.M., Pirone D.M., and Chen C.S. E-cadherin engagement stimulates proliferation via Rac1. J. Cell Biol. 173 (2006) 431-441
34. Kip1 gene is conserved in human and mouse and produces a long 5′-UTR. BMC Mol. Biol. 2 (2001) 12
35. Kip1 by tamoxifen. Biochem. Pharmacol. 66 (2003) 371-377
36. Fischer C., Sanchez-Ruderisch H., Welzel M., Wiedenmann B., Sakai T., Andre S., Gabius H.J., Khachigian L., Detjen K.M., and Rosewicz S. Galectin-1 interacts with the α5β1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J. Biol. Chem. 280 (2005) 37266-37277
37. Kip1. Mol. Cell. Biol. 25 (2005) 4335-4348
38. Kip1 expression by E2F1: a negative feedback mechanism. J. Biol. Chem. 280 (2005) 12339-12343
39. Heinemeyer T., Wingender E., Reuter I., Hermjakob H., Kel A.E., Kel O.V., Ignatieva E.V., Ananko E.A., Podkolodnaya O.A., Kolpakov F.A., Podkolodny N.L., and Kolchanov N.A. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26 (1998) 362-367
40. Le Mee S., Fromigue O., and Marie P.J. Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp. Cell Res. 302 (2005) 129-142
41. Sekido R., Murai K., Funahashi J., Kamachi Y., Fujisawa-Sehara A., Nabeshima Y., and Kondoh H. The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation. Mol. Cell. Biol. 14 (1994) 5692-5700
42. 1. Science 269 (1995) 1270-1272
43. CIP1 via Cdc42/Rac1 signaling. Mol. Cell. Biol. 22 (2002) 4587-4597
44. Ren X.D., Kiosses W.B., and Schwartz M.A. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18 (1999) 578-585
45. 1 to S phase in growth-stimulated rat FRTL-5 cells. J. Biol. Chem. 272 (1997) 13-16
46. Nakagawa M., Fukata M., Yamaga M., Itoh N., and Kaibuchi K. Recruitment and activation of Rac1 by the formation of E-cadherin-mediated cell-cell adhesion sites. J. Cell Sci. 114 (2001) 1829-1838
47. Charrasse S., Meriane M., Comunale F., Blangy A., and Gauthier-Rouviere C. N-cadherin-dependent cell-cell contact regulates Rho GTPases and beta-catenin localization in mouse C2C12 myoblasts. J. Cell Biol. 158 (2002) 953-965
48. Schwarze S.R., and Dowdy S.F. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21 (2000) 45-48